Nordwand Advisors »

Sunshine Biopharma shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Sunshine Biopharma shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Sunshine Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sunshine Biopharma held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sunshine Biopharma by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6k 500 3.18

More positions owned by Nordwand Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Johnson & Johnson (JNJ)
Novocure Ord Shs (NVCR)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Income Etf (JPIE)
Grab Holdings Class A Ord (GRAB)
Harbor Etf Trust Internatnal Comp (OSEA)
Ardagh Metal Packaging S A SHS (AMBP)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Mp Materials Corp Com Cl A (MP)
Oaktree Specialty Lending Corp (OCSL)
Series Portfolios Tr Panagram Bbb B (CLOZ)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Nordwand Advisors

Top funds holding Sunshine Biopharma

Bank of America Corporation
Nordwand Advisors
National Bank Of Canada /fi/
Jaffetilchin Investment Partners
Advisor Group Holdings
Rise Advisors
Farther Finance Advisors
TD Waterhouse Canada
Federation des caisses Desjardins du Quebec

View all funds holding Sunshine Biopharma